Sofwave Medical reported a strong first quarter for fiscal 2026, with revenue rising 46% year-over-year to $24.4 million and net income turning positive at $1.3 million under IFRS. The company saw a 56% increase in recurring usage fees, reflecting growing adoption of its non-invasive aesthetic treatments, especially among patients using GLP-1 therapies. Gross margin remained robust at 75%, and operating expenses as a percentage of revenue decreased, signaling improved efficiency. With nearly 2,900 systems sold and over 865,000 treatments performed, Sofwave is capitalizing on rising demand for regenerative aesthetic solutions and plans to continue expanding its global market presence.
Vanadi Coffee, a Spanish coffee franchise that shifted to holding bitcoin, is embroiled in internal conflict as a major shareholder, Vallecid, demands board renewal and scrutiny over high fees charged by board members on bitcoin financing transaction...
World Copper Ltd. has agreed to settle $209,000 of debt by issuing 20.9 million common shares at a deemed price of $0.01 per share to two directors and a service provider. This move helps the company conserve cash for working capital. The share issua...
Nvidia's Kyber rack-scale architecture, designed to house its 2027 Rubin Ultra chips, has been delayed to 2028 due to difficulties in manufacturing a key circuit board. This delay disrupts Nvidia's aggressive product release schedule and may allow co...
Amkor Technology has been upgraded from a hold to a buy rating due to its strong growth prospects, low debt-to-equity ratio, and expanding global supply chain. The company has shown earnings improvement, opened a new facility in Arizona, and experien...
Lockheed Martin is close to acquiring Ultra Maritime, a naval defense company specializing in anti-submarine technology, for about $3.5 billion. Ultra, owned by Advent International, produces radar, electronic warfare systems, and torpedo defense cou...
